20 May 2019 1 Min Read
Aspen to raise R1.9bn by selling a portfolio of products
Drugmaker, whose shares have more than halved since September 2018 on concerns that the group has too much debt, will use the proceeds to reduce gearing
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In